Transcription profile of hematopoietic CD34+cells from patients with myelodysplastic syndrome.

被引：0
|
作者：
Aivado, M
Germing, U
Gattermann, N
Steidl, U
Junge, B
Strupp, C
Giagounidis, AAN
Kobbe, G
Kronenwett, R
Aul, C
Bojar, H
Haas, R
机构：
[1] Univ Dusseldorf, D-4000 Dusseldorf, Germany
[2] St Johannes Univ, Duisburg, Germany
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
622
引用
收藏
页码：166A / 166A
页数：1
相关论文
共 50 条
  • [21] Expression profiling of CD34+cells in patients with myelodysplastic syndromes with and without a del(5q)
    Pellagatti, A
    Cazzola, M
    Giagounidis, A
    Malcovati, L
    Killick, S
    Ramasamy, A
    Oscier, D
    Aul, C
    Wainscoat, JS
    Boultwood, J
    EXPERIMENTAL HEMATOLOGY, 2005, 33 (07) : 60 - 60
  • [22] Karyotypic abnormalities in myelodysplastic syndrome do not correlate with increased number of CD34+cells in the bone marrow.
    Machhi, J
    van Tuinen, P
    Chang, C
    Shidham, VB
    Path, MRC
    Eshoa, C
    Kampalath, B
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 114 (04) : 650 - 651
  • [23] Effects of Imetelstat on CD34+Cells of Patients with Myelofibrosis
    Wang, Xiaoli
    Hu, Cing Siang
    Li, Yan
    Qiu, Jiajing
    Lam, Morgan
    Eng, Kevin
    Hoffman, Ronald
    BLOOD, 2014, 124 (21)
  • [24] Short- and long-term engraftment of CD34-and CD34+cells from mobilized blood differs from that of CD34-and CD34+cells from marrow.
    Verfaillie, CM
    Almeido-Porada, G
    Wissink, S
    Zanjani, ED
    BLOOD, 1999, 94 (10) : 133A - 133A
  • [25] CD34+cells in patients with non-ST elevation acute coronary syndrome
    Ruda, M. M.
    Vyborov, O. N.
    Arefieva, T. I.
    Karpov, Y. A.
    Parfyonova, Y. V.
    EUROPEAN HEART JOURNAL, 2008, 29 : 443 - 443
  • [26] CYTOGENETIC CHARACTERIZATION OF CD34+HEMATOPOIETIC PROGENITOR CELLS AND MESENCHYMAL STROMAL CELLS IN MYELODYSPLASTIC SYNDROME (MDS)
    Pimenova, Maria
    Parovichnikova, Elena
    Kokhno, Alina
    Domracheva, Elena
    Manakova, Tatyana
    Saribekyan, Ruben
    Galtseva, Irina
    Savchenko, Valeriy
    HAEMATOLOGICA, 2013, 98 : 77 - 77
  • [27] Clinical significance of free circulating CD34 in patients with acute myeloid leukemia and myelodysplastic syndrome.
    Hodge, Menna
    Giles, Francis
    Abdool, Adam
    O'Brien, Susan
    Keating, Michael
    Jilani, Iman
    Estrov, Zeev
    Estey, Elihu
    Kantadian, Hagop
    Albitar, Maher
    BLOOD, 2006, 108 (11) : 203B - 203B
  • [28] Demethylation profiling of CD34-positive hematopoietic cells in patients with myelodysplastic syndromes.
    D'Alo', F
    Giachelia, M
    Di Ruscio, A
    Gumiero, D
    Fabiani, E
    Voso, MT
    Leone, G
    BLOOD, 2005, 106 (11) : 960A - 960A
  • [29] Conservation of the potential of primitive hematopoietic cells obtained by amplification of CD34+cells from cord blood.
    Douay, L
    Kobari, L
    Pflumio, F
    Giarratana, MC
    Barret, C
    Vergé, V
    Coulombel, L
    BLOOD, 1999, 94 (10) : 606A - 606A
  • [30] Reduced CD38 Expression on CD34+Cells as a Diagnostic Test in Myelodysplastic Syndromes.
    Vyas, Paresh
    Goardon, Nicolas
    Stemberg, Alexander
    Chu, Wai-Kit
    Craddock, Charles F.
    Benson, Richard
    Freeman, Sylvie
    BLOOD, 2008, 112 (11) : 922 - 923
12345